Research ArticleCancer

Targeting MYCN-expressing triple-negative breast cancer with BET and MEK inhibitors

See allHide authors and affiliations

Science Translational Medicine  11 Mar 2020:
Vol. 12, Issue 534, eaaw8275
DOI: 10.1126/scitranslmed.aaw8275

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article